Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Advertisement

Experimental & Molecular Medicine
  • View all journals
  • Search
  • My Account Login
  • Content Explore content
  • About the journal
  • Publish with us
  • Sign up for alerts
  • RSS feed
  1. nature
  2. experimental & molecular medicine
  3. articles
  4. article
The homotrimeric structure of HtrA2 is indispensable for executing its serine protease activity
Download PDF
Download PDF
  • Article
  • Open access
  • Published: 01 February 2006

The homotrimeric structure of HtrA2 is indispensable for executing its serine protease activity

  • Min-Kyung Nam1,
  • Young-Mo Seong,
  • Hyo-Jin Park,
  • Ju-Youn Choi,
  • Seongman Kang &
  • …
  • Hyangshuk Rhim 

Experimental & Molecular Medicine volume 38, pages 36–43 (2006)Cite this article

  • 1103 Accesses

  • 16 Citations

  • Metrics details

Abstract

Serine protease activity of high temperature requrement 2 (HtrA2) is essential for promoting cell death, as well as for protecting against cellular stresses. An X-ray crystallographic study described the formation of a pyramid shaped homotrimer that is a proteolytically competent form of HtrA2; however, little is known about effects of the trimeric structure of HtrA2 on the natural substrates. In this study, we generated the HtrA2 protein that has a single point mutation at the homotrimerization motif to assess relationship between structure and the proteolytic activity of HtrA2 on its substrates. Using gel filtration, a native gel electrophoresis system, and a co-precipitation assay, we confirm that phenylalanine 149 in HtrA2 is a crucial determinant for the formation of the HtrA2 homotrimeric structure. Moreover, we described that the HtrA2 monomeric form abolished not only autoproteolytic activity, but also the proteolytic activity against XIAP (X-linked inhibitor of apoptosis protein) known as the HtrA2 substrate. Taken together, the results indicate that the homotrimeric structure of HtrA2 is required for executing its serine protease activity.

Similar content being viewed by others

Structural basis of substrate recognition and allosteric activation of the proapoptotic mitochondrial HtrA2 protease

Article Open access 30 May 2024

Rational correction of pathogenic conformational defects in HTRA1

Article Open access 16 July 2024

Borrelia burgdorferi serine protease HtrA is a pleiotropic regulator of stress response, motility, flagellar hemostasis, and infectivity

Article Open access 01 March 2025

Article PDF

Author information

Authors and Affiliations

  1. Research Institute of Molecular Genetics, Catholic University, Seoul, 137-701, Korea

    Min-Kyung Nam

Authors
  1. Min-Kyung Nam
    View author publications

    Search author on:PubMed Google Scholar

  2. Young-Mo Seong
    View author publications

    Search author on:PubMed Google Scholar

  3. Hyo-Jin Park
    View author publications

    Search author on:PubMed Google Scholar

  4. Ju-Youn Choi
    View author publications

    Search author on:PubMed Google Scholar

  5. Seongman Kang
    View author publications

    Search author on:PubMed Google Scholar

  6. Hyangshuk Rhim
    View author publications

    Search author on:PubMed Google Scholar

Rights and permissions

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and permissions

About this article

Cite this article

Nam, MK., Seong, YM., Park, HJ. et al. The homotrimeric structure of HtrA2 is indispensable for executing its serine protease activity. Exp Mol Med 38, 36–43 (2006). https://doi.org/10.1038/emm.2006.5

Download citation

  • Published: 01 February 2006

  • Issue date: 01 February 2006

  • DOI: https://doi.org/10.1038/emm.2006.5

Share this article

Anyone you share the following link with will be able to read this content:

Sorry, a shareable link is not currently available for this article.

Provided by the Springer Nature SharedIt content-sharing initiative

Keywords

  • Omi serine protease
  • protein structure
  • tertiary
  • serine endopeptidases
  • structure-activity relationships
  • X-linked inhibitor of apoptosis protein
Download PDF

Advertisement

Explore content

  • Research articles
  • Reviews & Analysis
  • News & Comment
  • Current issue
  • Collections
  • Sign up for alerts
  • RSS feed

About the journal

  • Special Feature
  • Journal Information
  • About the Editors
  • About the Partner
  • Contact
  • For Advertisers
  • Press Releases
  • Open Access Fees and Funding

Publish with us

  • For Authors & Referees
  • Language editing services
  • Submit manuscript

Search

Advanced search

Quick links

  • Explore articles by subject
  • Find a job
  • Guide to authors
  • Editorial policies

Experimental & Molecular Medicine (Exp Mol Med)

ISSN 2092-6413 (online)

ISSN 1226-3613 (print)

nature.com sitemap

About Nature Portfolio

  • About us
  • Press releases
  • Press office
  • Contact us

Discover content

  • Journals A-Z
  • Articles by subject
  • protocols.io
  • Nature Index

Publishing policies

  • Nature portfolio policies
  • Open access

Author & Researcher services

  • Reprints & permissions
  • Research data
  • Language editing
  • Scientific editing
  • Nature Masterclasses
  • Research Solutions

Libraries & institutions

  • Librarian service & tools
  • Librarian portal
  • Open research
  • Recommend to library

Advertising & partnerships

  • Advertising
  • Partnerships & Services
  • Media kits
  • Branded content

Professional development

  • Nature Awards
  • Nature Careers
  • Nature Conferences

Regional websites

  • Nature Africa
  • Nature China
  • Nature India
  • Nature Japan
  • Nature Middle East
  • Privacy Policy
  • Use of cookies
  • Legal notice
  • Accessibility statement
  • Terms & Conditions
  • Your US state privacy rights
Springer Nature

© 2025 Springer Nature Limited